Key result
Vasodilators show inconsistent benefits on LV function and outcomes in asymptomatic chronic aortic regurgitation.
Why the study?
It is uncertain whether pharmacological therapy with vasodilators can preserve LV function and delay aortic valve replacement in asymptomatic chronic aortic regurgitation.
Do vasodilators preserve LV function and delay the need for aortic valve replacement in asymptomatic patients with chronic aortic regurgitation?
Do vasodilators preserve LV function and delay the need for aortic valve replacement in asymptomatic patients with chronic aortic regurgitation?
Current evidence for vasodilator therapy in asymptomatic chronic aortic regurgitation is inconsistent and insufficient to draw definite conclusions, requiring decisions to be based on clinical judgment.
Answers are grounded in this paper and cite their sources.
Evidence too limited for routine vasodilator use in asymptomatic chronic AR; leaves open whether larger trials will clarify benefit.
Chronic aortic regurgitation results in left ventricular (LV) dilation, increased LV work and, eventually, a decline in LV function and heart failure. An important question is whether pharmacological therapy could preserve LV function and delay the need for aortic valve replacement. Vasodilators have a number of theoretical advantages. By lowering blood pressure, they reduce the regurgitant volume and decrease LV afterload. This article summarizes the clinical studies that have evaluated vasodilators in asymptomatic patients with chronic aortic regurgitation. Some studies suggest favorable effects on LV function and clinical outcomes, but results are inconsistent, making it difficult to draw definite conclusions. In general, studies have been too small to reliably evaluate the overall benefits and risks of this treatment, and in several studies there was no significant difference in measured blood pressure by treatment allocation. For these reasons, decisions on whether vasodilators are indicated in individual patients must currently be based on clinical judgment alone.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2011) conducted a review in asymptomatic chronic aortic regurgitation. Vasodilators was evaluated. Vasodilators for asymptomatic chronic aortic regurgitation show inconsistent effects on LV function and clinical outcomes, with existing studies being too small to draw definite conclusions.
Synapse has enriched 10 related papers. Consider them for comparative context: